Future HIV Therapy

Aims & Scope

Cessation.

Substantial advances in the development of antiretroviral drugs and clinical management are being achieved in the field of HIV and AIDS, although many research challenges remain.

In recognition of an increased focus on contemporary clinical challenges and disease management issues, Future HIV Therapy (ISSN: 1746-9600) will simply be titled HIV Therapy (ISSN: 1758-4310) from January 2009.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• 14th Conference on Retroviruses and Opportunistic Infections (CROI 2007)

  Citation: 40

  Authors: Bernard

• Developing Neuroprotective Strategies for Treatment of HIV-Associated Neurocognitive Dysfunction

  Citation: 27

  Authors: Jeffrey A, Joseph, Ned, Avindra

• Male Circumcision is an Efficacious, Lasting and Cost-Effective Strategy for Combating HIV in High-Prevalence AIDS Epidemics

  Citation: 27

  Authors: Daniel T, Richard G, Helen A, Catherine, Kawango, Quarraisha Abdool, Olive, Robert C, Bilonda, John, Kasonde, Richard, Ward, Mamadou Otto, Sibongile, Nathan, Mark, Helen, Patrick Kalambayi, Saidi, Poloko, Leon, Jeffrey D, Suzanne, Khanya, Mzamani Benjamin, Kenneth, Brian J, Antonio, Johanna, Innocent, Obrian F, Emmanuel Oladipo, Jean William, Mannasseh, Helen, Monica, Jorge, Sharif, Esther Salang, David M, Geoffrey, Nelson, Dudu, François, David, Godfrey, Nompumelelo

• Etravirine: A Second-Generation Nnrti for Treatment-Experienced Adults with Resistant HIV-1 Infection

  Citation: 23

  Authors: Joshua J, Richard

• Biologically Active Coumarins as Inhibitors of HIV-1

  Citation: 22

  Authors: Irena, Jan

• Is Male Circumcision as Good as the HIV Vaccine We‘Ve Been Waiting For?

  Citation: 20

  Authors: Jeffrey D, Richard G, Kasonde, Kawango, Jesse, Daniel T

• Male Circumcision is <i>Not</i> the HIV ‘Vaccine’ We Have Been Waiting For!

  Citation: 19

  Authors: Lawrence W, Ryan G, Kent W, John W

• Are We Ready for Home-Based, Self-Testing for Hiv?

  Citation: 19

  Authors: Nitika, Marina B

• Oxidative Stress and HIV Infection: Target Pathways for Novel Therapies?

  Citation: 18

  Authors: Stefano, Fernanda, Michela, Carlo Federico

• Nanotechnology-Based Delivery Systems in Hiv/Aids Therapy

  Citation: 16

  Authors: Aliasgar, Mansoor M